Postsurgical treatment with pembrolizumab doubles cancer-free time for bladder cancer patients

Results from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time people with high-risk, muscle-invasive bladder cancer are cancer-free following surgical removal of the bladder.

Arie Belldegrun and team unveil $600M life sciences credit firm amid struggling biotech market

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 7, 2024

Chickpea’s secret history: How trade routes and migrations shaped the legume’s genetic heritage

With its nutty flavor and dense nutrient profile, the humble chickpea has captivated palates and nourished civilizations for millennia.

June 23, 2023

Rural clinics significantly boost buprenorphine prescribing with support program

Despite the removal of the X-waiver requirement, which once restricted clinicians from prescribing buprenorphine for opioid use disorder (OUD), only a small percentage of primary

January 28, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.